GKOS Insider Trading

Glaukos Corporation (GKOS) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $14.55B, listed on NYSE, employing roughly 1,094 people, carrying a beta of 0.69 to the broader market. Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. Led by Thomas William Burns, public since 2015-06-25.

In the last 12 months, Glaukos Corporation insiders made 0 buy transactions and 65 sale transactions.

DateNameTypeSharesPriceValue
Nov 5, 2026Kliman Gilbert HM-Exempt2,500$25.77$64.4K
Nov 5, 2026Kliman Gilbert HS-Sale2,500$253.00$632.5K
Nov 5, 2026Kliman Gilbert HM-Exempt2,500$25.77$64.4K
Nov 3, 2026WEISNER AIMEE SG-Gift2,382$0.00$0
Nov 3, 2026WEISNER AIMEE SG-Gift2,382$0.00$0
Nov 3, 2026Navratil TomasM-Exempt8,788$85.94$755.2K
Nov 3, 2026Navratil TomasM-Exempt4,181$55.00$230.0K
Nov 3, 2026Navratil TomasS-Sale10,221$237.54$2.4M
Nov 3, 2026Navratil TomasS-Sale12,836$238.56$3.1M
Nov 3, 2026Navratil TomasS-Sale14,943$239.64$3.6M

GKOS Insider Activity by Quarter

Reported Form 4 and Form 5 lines under GKOS's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Feb 14, 2024, and a quarter counts only when every filing for it was read. Last refreshed Nov 6, 2026.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)0N/A8$11.5M8
Q3 20260N/A23$22.7M17
Q2 20260N/A10$6.3M40
Q1 20260N/A21$27.7M65
Q4 20250N/A3$2.3M9
Q3 20250N/A5$497.2K8
Q2 20250N/A0N/A27
Q1 20250N/A5$3.2M42
Q4 20240N/A5$2.6M24

GKOS Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 366 institutions reported holding 60,804,214 GKOS shares, valued at $8.46B as reported, 100.9% of its market cap (market cap of Jun 26, 2026). That is +30 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 64 opened a position, 34 closed one, 147 added and 103 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
BlackRock, Inc.9,540,056$1.33B+450,027
Jupiter Topco LLC4,862,894$679.6MNo comparable report
VANGUARD PORTFOLIO MANAGEMENT LLC3,321,839$464.3M+113,476
PRIMECAP MANAGEMENT CO/CA/3,040,705$425.0M-329,923
VANGUARD CAPITAL MANAGEMENT LLC2,551,132$356.5M+42,361
STATE STREET CORP2,315,568$323.7M+132,951
MILLENNIUM MANAGEMENT LLC1,581,016$221.0M+407,320
Holocene Advisors, LP1,514,931$211.7M+131,216
GEODE CAPITAL MANAGEMENT, LLC1,463,448$204.6M+106,995
CITADEL ADVISORS LLC1,390,017$194.3M-56,909

By Quarter

QuarterInstitutionsSharesValue
Q2 202636660,804,214$8.46B
Q1 202633657,985,000$6.25B
Q4 202533257,107,484$6.45B
Q3 202531556,595,260$4.62B
Q2 202529761,235,291$6.32B
Q1 202531657,126,665$5.67B
Q4 202432157,145,013$8.57B
Q3 202431354,741,223$7.13B
Q2 202428356,274,947$6.66B

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding GKOS

FundWeight of GKOSShares (as reported)Value (as reported)Source updated
IJH iShares Core S&P Mid-Cap ETF0.42%2,133,129$527.2MNov 12, 2026
IWM iShares Russell 2000 ETF0.47%1,493,324$369.1MNov 12, 2026
IWO iShares Russell 2000 Growth ETF0.94%544,244$134.5MNov 12, 2026
MDY State Street SPDR S&P MIDCAP 400 ETF Trust0.42%440,688$109.0MNov 12, 2026
BLCR iShares Large Cap Core Active ETF0.82%329,069$81.3MNov 12, 2026
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.42%324,314$80.2MNov 12, 2026
SCHA Schwab U.S. Small-Cap ETF0.35%314,981$77.5MNov 13, 2026
IHI iShares U.S. Medical Devices ETF1.80%297,958$73.6MNov 12, 2026
FESM Fidelity Enhanced Small Cap ETF1.03%288,863$71.4MNov 13, 2026
IJK iShares S&P Mid-Cap 400 Growth ETF0.58%251,236$62.1MNov 12, 2026
SCHM Schwab U.S. Mid-Cap ETF0.30%179,883$44.3MNov 13, 2026
IJJ iShares S&P Mid-Cap 400 Value ETF0.26%92,168$22.8MNov 12, 2026
ITOT iShares Core S&P Total U.S. Stock Market ETF0.02%78,633$19.4MNov 12, 2026
MDYG State Street SPDR S&P 400 Mid Cap Growth ETF0.59%68,172$16.8MNov 12, 2026
JMEE JPMorgan Small & Mid Cap Enhanced Equity ETF0.42%50,750$12.5MNov 12, 2026

From each fund's latest holdings file on record that shows GKOS's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as GKOS's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for GKOS reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is GKOS's share of that fund.

How to Read GKOS Insider Activity

Net insider sentiment skews to the sell side over the trailing twelve months: 65 sales versus 0 buys. Insider sales carry less informational weight than buys because they are often driven by liquidity, tax planning, or pre-scheduled Rule 10b5-1 trading plans rather than negative information. The transaction type alone does not say whether a sale was made on the open market or privately, or under a 10b5-1 plan; the filing's plan checkbox and footnotes do. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked GKOS insider trading questions

How active are GKOS insiders right now?
Over the trailing twelve months, Glaukos Corporation (GKOS) insiders made 0 buy transactions and 65 sale transactions. Net insider sentiment over the trailing twelve months tilts to the sell side (65 sales vs 0 buys). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are GKOS insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do GKOS insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.